Chemclin Diagnostics Co (SHSE:688468) Marketable Securities: ¥231.5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688468 Chemclin Diagnostics Co Ltd SHSE:688468
75 GF Score
Price ¥6.34
GF Value ¥6.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Chemclin Diagnostics Co Marketable Securities?

Chemclin Diagnostics Co SHSE:688468 -1.40% 75 Marketable Securities is ¥231.5 Mil as of Jun. 2026. GuruFocus rates SHSE:688468 with a GF Score™ of 75/100 and a GF Value™ of ¥6.14 (Fairly Valued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Chemclin Diagnostics Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥231.5 Mil.

Chemclin Diagnostics Co's annual Marketable Securities increased from Dec. 2023 (¥470.0 Mil) to Dec. 2024 (¥509.0 Mil) but then declined from Dec. 2024 (¥509.0 Mil) to Dec. 2025 (¥301.2 Mil).

Chemclin Diagnostics Co  (SHSE:688468) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Chemclin Diagnostics Co Marketable Securities Related Terms

Chemclin Diagnostics Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Chemclin Diagnostics Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemclin Diagnostics Co Marketable Securities Chart

Chemclin Diagnostics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 613.00 643.00 470.00 509.00 301.22

Chemclin Diagnostics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 375.00 215.00 301.22 270.55 231.53
SHSE:688468
75GF Score
Chemclin Diagnostics Co Ltd SHSE:688468
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemclin Diagnostics Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥231.5 Mil mean?
Chemclin Diagnostics Co (SHSE:688468) has a Marketable Securities of ¥231.5 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chemclin Diagnostics Co and its competitors.
Is Chemclin Diagnostics Co's Marketable Securities too high?
Chemclin Diagnostics Co's current Marketable Securities is ¥231.5 Mil. Overall, Chemclin Diagnostics Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemclin Diagnostics Co's Marketable Securities compare to TMO and DHR?
Chemclin Diagnostics Co's Marketable Securities of ¥231.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chemclin Diagnostics Co and its competitors. Chemclin Diagnostics Co's current Marketable Securities is ¥231.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemclin Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Chemclin Diagnostics Co (SHSE:688468) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.14, compared to a current price of ¥6.34 — trading 3.3% above its estimated fair value. The current Marketable Securities is ¥231.5 Mil. Chemclin Diagnostics Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Chemclin Diagnostics Co (SHSE:688468), the current Marketable Securities is ¥231.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemclin Diagnostics Co (SHSE:688468) Overvalued in 2026?

Based on GuruFocus' analysis, Chemclin Diagnostics Co stock appears to be overvalued. The current stock price of ¥6.34 is trading 3.3% above its estimated GF Value™ of ¥6.14. GuruFocus considers Chemclin Diagnostics Co to be Fairly Valued.

Key valuation signals for SHSE:688468:

  • Marketable Securities: ¥231.5 Mil
  • GF Value™: ¥6.14 vs. price of ¥6.34 (3.3% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemclin Diagnostics Co Business Description

Address No. 7 Fengxian Middle Road, 6th & 7th Floor Incubator Building, Beike Modern Manufacturing Park, Yongfeng Base, Haidian District, Beijing, CHN, 100094
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
75GF Score

Get the complete analysis for SHSE:688468

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.34
Price
¥6.14
GF Value